Prognostic and predictive factors in oral squamous cell cancer: important tools for planning individual therapy?

This publication has 102 references indexed in Scilit:

• Current role of gene therapy in head and neck cancer
  European Journal of Surgical Oncology, 2000
• The EORTC randomized trial on three fractions per day and misonidazole in advanced head and neck cancer: prognostic factors
  Radiotherapy and Oncology, 1995
• ras Mutations and expression in head and neck squamous cell carcinomas
  The Laryngoscope, 1994
• Stat3: a STAT Family Member Activated by Tyrosine Phosphorylation in Response to Epidermal Growth Factor and Interleukin-6
  Science, 1994
• A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
  Nature, 1993
• Estimates of the worldwide incidence of eighteen major cancers in 1985
  International Journal of Cancer, 1993
• p53, guardian of the genome
  Nature, 1992
• Argyrophilic nucleolar organizer region counts and proliferating cell nuclear antigen scores are two reliable indicators of survival in pharyngeal carcinoma
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1992
• Long-term results in treating squamous cell carcinoma of the lip, oral cavity, and oropharynx
  International Journal of Oral & Maxillofacial Surgery, 1989
• Expression of epidermal growth factor receptor on oral squamous cell carcinoma
  British Journal of Oral and Maxillofacial Surgery, 1988